https://www.selleckchem.com/pr....oducts/sitagliptin.h
Non-rectal cancer was more common in the non-CCRP group (81.5% vs. 57.6%, .001). The non-CCRP group had lower median Hb-value (106, IQR 87-129 vs. 117, IQR 101-136, = .001). 85% of the non-CCRP group was found to meet one or more CCRP referral criteria, with bleeding anemia being the dominant criterion to meet. The CCRP did not appear to improve prognostic outcomes for CRC-patients. NCT04585516. The CCRP did not appear to improve prognostic outcomes for CRC-patients. ClinicalTrials.gov Identifier NCT04585516.Crotonaldehyde is a
Like
Comment
Share
